person · Reporting owner

BlueLine Capital Partners II, L.P.

Disclosed activity across 3 companies

Tapewire entity: 144782
SEC CIK: 0001460781

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CYANOTECH CORPCYAN · Entity 8431	10% owner	November 07, 2018	November 09, 2018
IRIDEX CORPIRIX · Entity 7882	10% owner	November 21, 2017	November 22, 2017
InfuSystem Holdings, IncINFU · Entity 6163	Director	December 07, 2020	December 09, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CYANOTECH CORP

Report date November 07, 2018 · Filed November 09, 2018

Jointly reported with Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Partners, L.L.C.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	850,116	Reported balance After 2018-11-07 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2018-11-07 · Other · Acquired 100,506 · Balance 850,116 F1: These securities are owned by Meridian TSV II, LP. The shares were contributed to that entity by a limited partner in such entity. F2: As described in the Schedule 13D filing made on May 9, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

Filing footnotes · ownership attribution and instrument terms

F1: These securities are owned by Meridian TSV II, LP. The shares were contributed to that entity by a limited partner in such entity.

F2: As described in the Schedule 13D filing made on May 9, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

IRIDEX CORP

Report date November 21, 2017 · Filed November 22, 2017

Jointly reported with BlueLine Capital Partners, L.P., BlueLine Capital Partners III, LP, BlueLine Partners, L.L.C., BlueLine Partners II, LLC, BlueLine Catalyst Fund IX, L.P.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,138,862	Reported balance After 2017-11-21 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2017-11-21 · Other · Disposed 267,631 · Balance 1,138,862 F1: These securities were owned by BlueLine Capital Partners III, L.P. On November 21, 2017, BlueLine Capital Partners III, L.P. executed an in-kind distribution, without consideration, of 267,631 shares of the Issuer's common stock to certain of its limited partners. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. F2: As described in Amendment No. 4 to Schedule 13D ("Amendment No. 4") filed on October 25, 2007 with respect to the securities owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund VIII, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., and BlueLine Partners II, L.L.C., as of the date of Amendment No. 4, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Entity may have been deemed to have beneficial ownership of 10% or more of the securities. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement.

Filing footnotes · ownership attribution and instrument terms

F1: These securities were owned by BlueLine Capital Partners III, L.P. On November 21, 2017, BlueLine Capital Partners III, L.P. executed an in-kind distribution, without consideration, of 267,631 shares of the Issuer's common stock to certain of its limited partners. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement.

F2: As described in Amendment No. 4 to Schedule 13D ("Amendment No. 4") filed on October 25, 2007 with respect to the securities owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund VIII, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., and BlueLine Partners II, L.L.C., as of the date of Amendment No. 4, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Entity may have been deemed to have beneficial ownership of 10% or more of the securities. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement.

InfuSystem Holdings, Inc

Report date December 07, 2020 · Filed December 09, 2020

Jointly reported with Meridian OHC LLC, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Partners, L.L.C.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	493,656	Last balance in matching sequence After 2020-12-09 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 3 source rows Row 1 · 2020-12-07 · Sale · Disposed 2,900 · Balance 499,850 F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Row 2 · 2020-12-08 · Sale · Disposed 4,489 · Balance 495,361 F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Row 3 · 2020-12-09 · Sale · Disposed 1,705 · Balance 493,656 F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Filing footnotes · ownership attribution and instrument terms

F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 09, 2020 Filed Dec 9, 2020 17:40 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	SaleCommon Stock	1,705	$17.00	$28,985.00	Disclosure SEC source: 0001096906-20-000461 · form4.xml · nonDerivative · entry 3 BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,656 F1 · ownership.direct: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
December 08, 2020 Filed Dec 9, 2020 17:40 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	SaleCommon Stock	4,489	$17.04	$76,492.56	Disclosure SEC source: 0001096906-20-000461 · form4.xml · nonDerivative · entry 2 BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,361 F1 · ownership.direct: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
December 07, 2020 Filed Dec 9, 2020 17:40 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	SaleCommon Stock	2,900	$17.21	$49,909.00	Disclosure SEC source: 0001096906-20-000461 · form4.xml · nonDerivative · entry 1 BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,850 F1 · ownership.direct: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
September 30, 2020 Filed Oct 2, 2020 18:09 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	OtherCommon Stock	273,457	$0.00	$0.00	Disclosure SEC source: 0001445866-20-001474 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502,750 F2 · ownership.direct: These securities were owned by Meridian TSV II, LP. On September 30, 2020, Meridian TSV II, LP. executed an in-kind distribution, without consideration, of 273,457 of the Issuer's common stock to certain of its limited partners. Read SEC document
September 30, 2020 Filed Oct 2, 2020 18:09 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	OtherCommon Stock	2,009,580	$0.00	$0.00	Disclosure SEC source: 0001445866-20-001474 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 776,207 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. On September 30, 2020, Meridian OHC Partners, LP executed an in-kind distribution, without consideration, of 2,009,580 of the Issuer's common stock to certain of its limited partners. Read SEC document
September 29, 2020 Filed Sep 30, 2020 18:04 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	SaleCommon Stock	45,604	$13.89	$633,439.56	Disclosure SEC source: 0001445866-20-001428 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,740,183 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
September 28, 2020 Filed Sep 30, 2020 18:04 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	SaleCommon Stock	37,300	$13.93	$519,589.00	Disclosure SEC source: 0001445866-20-001428 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,785,787 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
June 30, 2020 Filed Jun 30, 2020 18:15 UTC	InfuSystem Holdings, Inc infu · Entity 6163	SaleCommon Stock	400,000	$11.00	$4,400,000.00	Disclosure SEC source: 0001445866-20-000935 · primary_doc.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001338294 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,823,087 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. Read SEC document
June 29, 2020 Filed Jun 29, 2020 18:22 UTC	InfuSystem Holdings, Inc infu · Entity 6163	SaleCommon Stock	20,350	$11.87	$241,554.50	Disclosure SEC source: 0001445866-20-000924 · primary_doc.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001338294 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,223,087 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
June 28, 2020 Filed Jun 29, 2020 18:22 UTC	InfuSystem Holdings, Inc infu · Entity 6163	SaleCommon Stock	794	$12.09	$9,599.46	Disclosure SEC source: 0001445866-20-000924 · primary_doc.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001338294 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,243,437 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
June 25, 2020 Filed Jun 29, 2020 18:22 UTC	InfuSystem Holdings, Inc infu · Entity 6163	SaleCommon Stock	95,529	$12.33	$1,177,872.57	Disclosure SEC source: 0001445866-20-000924 · primary_doc.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001338294 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,244,231 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
June 11, 2020 Filed Jun 12, 2020 18:08 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	OtherCommon Stock	16,801	$0.00	$0.00	Disclosure SEC source: 0001445866-20-000847 · form4.xml · nonDerivative · entry 1 BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,339,760 F1 · ownership.direct: These securities were owned by BlueLine Capital Partners II, LP. On June 11, 2020, BlueLine Capital Partners II, LP executed an in-kind distribution, without consideration, of 16,801 shares of the Issuer's common stock to certain of its limited partners. BlueLine Partners, LLC is the general partner of BlueLine Capital Partners II, LP, and Scott Shuda is managing director of BlueLine Partners, LLC. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. Read SEC document
March 31, 2020 Filed Mar 31, 2020 22:03 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	SaleCommon Stock	169,960	$8.37	$1,422,531.21	Disclosure SEC source: 0001445866-20-000310 · primary_doc.xml · nonDerivative · entry 1 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote 1 Disclosed balance after: 3,356,561 F1 · ownership.direct: These securities are owned by Imua T Capital Investments, LLC. The price reported in Column 4 is a weighted average price. These shares reported herein were traded in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares traded at each separate price. Imua T Capital Investments, LLC is a member of the group described in Amendment No. 1 to Schedule 13D filed by Meridian OHC Partners, LP and others on August 31, 2018. Imua T Capital Investments, LLC is managed separately from the other members of such group, and the securities reported transacting herein were all of the shares held by Imua T Capital Investments, LLC. Read SEC document
September 06, 2019 Filed Sep 6, 2019 20:42 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	2,000	$5.05	$10,100.00	Disclosure SEC source: 0001445866-19-001110 · form4.xml · nonDerivative · entry 3 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,526,521 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. Read SEC document
September 05, 2019 Filed Sep 6, 2019 20:42 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	2,000	$5.00	$10,000.00	Disclosure SEC source: 0001445866-19-001110 · form4.xml · nonDerivative · entry 2 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,524,521 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. Read SEC document
September 05, 2019 Filed Sep 6, 2019 20:42 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	1,004	$4.90	$4,919.60	Disclosure SEC source: 0001445866-19-001110 · form4.xml · nonDerivative · entry 1 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,522,521 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. Read SEC document
June 14, 2019 Filed Jun 17, 2019 20:44 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	1,123	$4.54	$5,098.42	Disclosure SEC source: 0001445866-19-000723 · form4.xml · nonDerivative · entry 3 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,521,517 F4 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. Read SEC document
June 14, 2019 Filed Jun 17, 2019 20:44 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	2,500	$4.54	$11,350.00	Disclosure SEC source: 0001445866-19-000723 · form4.xml · nonDerivative · entry 2 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,520,394 F4 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F2 · ownership.direct: These securities are owned by Scott Shuda. Read SEC document
June 14, 2019 Filed Jun 17, 2019 20:44 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	1,100	$4.43	$4,873.00	Disclosure SEC source: 0001445866-19-000723 · form4.xml · nonDerivative · entry 1 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,517,894 F4 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F1 · ownership.direct: These securities are owned by Meridian TSV II, LP Read SEC document
November 07, 2018 Filed Nov 9, 2018 13:49 UTC	CYANOTECH CORP CYAN · Entity 8431	OtherCommon Stock	100,506	$0.00	$0.00	Disclosure SEC source: 0001445866-18-001201 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850,116 F1 · ownership.direct: These securities are owned by Meridian TSV II, LP. The shares were contributed to that entity by a limited partner in such entity. F2 · ownership.direct: As described in the Schedule 13D filing made on May 9, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
June 14, 2018 Filed Jun 14, 2018 18:12 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	132,020	$3.10	$409,262.00	Disclosure SEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 5 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,346,834 F3 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
June 14, 2018 Filed Jun 14, 2018 18:12 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	15,000	$3.10	$46,500.00	Disclosure SEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 4 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,214,814 F2 · ownership.direct: These securities are owned by Meridian TSV II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
June 12, 2018 Filed Jun 14, 2018 18:12 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	10,000	$3.15	$31,500.00	Disclosure SEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,199,814 F2 · ownership.direct: These securities are owned by Meridian TSV II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
June 12, 2018 Filed Jun 14, 2018 18:12 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	162	$3.00	$486.00	Disclosure SEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,189,814 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
June 12, 2018 Filed Jun 14, 2018 18:12 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	5,000	$3.05	$15,250.00	Disclosure SEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,189,652 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
May 22, 2018 Filed May 22, 2018 18:05 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	5,000	$3.00	$15,000.00	Disclosure SEC source: 0001445866-18-000596 · form4.xml · nonDerivative · entry 4 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,184,652 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
May 18, 2018 Filed May 22, 2018 18:05 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	841	$2.85	$2,396.85	Disclosure SEC source: 0001445866-18-000596 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,179,652 F2 · ownership.direct: These securities are owned by Meridian TSV II, LP. Read SEC document
May 18, 2018 Filed May 22, 2018 18:05 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	944	$2.85	$2,690.40	Disclosure SEC source: 0001445866-18-000596 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,178,811 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
May 17, 2018 Filed May 22, 2018 18:05 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	5,000	$2.90	$14,500.00	Disclosure SEC source: 0001445866-18-000596 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,177,867 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. F3 · ownership.direct: The amount of securities beneficially owned by the Reporting Persons was incorrectly stated on the Form 4 filed on May 24, 2017 and was reflected in all subsequent reports but is being corrected with this Form 4 filing. Read SEC document
May 14, 2018 Filed May 14, 2018 16:57 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	2,055	$2.79	$5,733.45	Disclosure SEC source: 0001445866-18-000545 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,196,200 F2 · ownership.direct: These securities are owned by Meridian TSV II, LP. Read SEC document
May 14, 2018 Filed May 14, 2018 16:57 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	30,000	$2.80	$84,000.00	Disclosure SEC source: 0001445866-18-000545 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,194,145 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
May 10, 2018 Filed May 14, 2018 16:57 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	8,493	$2.60	$22,081.80	Disclosure SEC source: 0001445866-18-000545 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,164,145 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
March 16, 2018 Filed Mar 16, 2018 17:29 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	20,000	$2.40	$48,000.00	Disclosure SEC source: 0001445866-18-000266 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,155,652 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
December 13, 2017 Filed Dec 14, 2017 18:35 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	20,000	$2.35	$47,000.00	Disclosure SEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 5 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,115,652 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
December 13, 2017 Filed Dec 14, 2017 18:35 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	24,000	$2.30	$55,200.00	Disclosure SEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 4 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,095,652 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
December 13, 2017 Filed Dec 14, 2017 18:35 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	4,767	$2.30	$10,964.10	Disclosure SEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,071,652 F2 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
December 12, 2017 Filed Dec 14, 2017 18:35 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	3,233	$2.35	$7,597.55	Disclosure SEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,066,885 F2 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
December 12, 2017 Filed Dec 14, 2017 18:35 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	12,000	$2.32	$27,840.00	Disclosure SEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,063,652 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
December 08, 2017 Filed Dec 8, 2017 17:20 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	1,800	$2.30	$4,140.00	Disclosure SEC source: 0001445866-17-001749 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,051,652 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
December 07, 2017 Filed Dec 8, 2017 17:20 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	15,000	$2.35	$35,250.00	Disclosure SEC source: 0001445866-17-001749 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,049,852 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
December 06, 2017 Filed Dec 8, 2017 17:20 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	7,300	$2.30	$16,790.00	Disclosure SEC source: 0001445866-17-001749 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,034,852 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
November 21, 2017 Filed Nov 22, 2017 22:53 UTC	IRIDEX CORP IRIX · Entity 7882	OtherCommon Stock	267,631	$0.00	$0.00	Disclosure SEC source: 0001445866-17-001714 · form4.xml · nonDerivative · entry 1 BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners III, LP · CIK 0001411986 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner BlueLine Partners II, LLC · CIK 0001411987 · 10% owner BlueLine Catalyst Fund IX, L.P. · CIK 0001460518 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,138,862 F1 · ownership.direct: These securities were owned by BlueLine Capital Partners III, L.P. On November 21, 2017, BlueLine Capital Partners III, L.P. executed an in-kind distribution, without consideration, of 267,631 shares of the Issuer's common stock to certain of its limited partners. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. F2 · ownership.direct: As described in Amendment No. 4 to Schedule 13D ("Amendment No. 4") filed on October 25, 2007 with respect to the securities owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund VIII, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., and BlueLine Partners II, L.L.C., as of the date of Amendment No. 4, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Entity may have been deemed to have beneficial ownership of 10% or more of the securities. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. Read SEC document
September 11, 2017 Filed Sep 13, 2017 19:06 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	4,982	$2.00	$9,964.00	Disclosure SEC source: 0001445866-17-001315 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,027,552 F2 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
September 11, 2017 Filed Sep 13, 2017 19:06 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	15,000	$2.00	$30,000.00	Disclosure SEC source: 0001445866-17-001315 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,022,570 F1 · ownership.direct: These securities are owned by Meridian TSV II, LP. Read SEC document
September 08, 2017 Filed Sep 8, 2017 19:53 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	OtherCommon Stock	225,000	$2.00	$450,000.00	Disclosure SEC source: 0001445866-17-001311 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,007,570 F1 · ownership.direct: These securities are owned by Meridian TSV II, LP., and were acquired coincident to a subscription by a new limited partner to such entity. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document
August 30, 2017 Filed Aug 30, 2017 17:36 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	600	$1.90	$1,140.00	Disclosure SEC source: 0001445866-17-001281 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,782,570 F2 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
August 30, 2017 Filed Aug 30, 2017 17:36 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	300	$1.85	$555.00	Disclosure SEC source: 0001445866-17-001281 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,781,970 F2 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
August 28, 2017 Filed Aug 30, 2017 21:35 UTC	IRIDEX CORP IRIX · Entity 7882	OtherCommon Stock	54,195	$0.00	$0.00	Disclosure SEC source: 0001445866-17-001279 · form4.xml · nonDerivative · entry 1 BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner BlueLine Catalyst Fund IX, L.P. · CIK 0001460518 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners III, LP · CIK 0001411986 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner BlueLine Partners II, LLC · CIK 0001411987 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,406,493 F1 · ownership.direct: These securities were owned by BlueLine Capital Partners, L.P. On August 28, 2017, BlueLine Capital Partners, L.P. executed an in-kind distribution, without consideration, of 54,195 shares of the Issuer's common stock to certain of its limited partners. Read SEC document
August 28, 2017 Filed Aug 30, 2017 17:36 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	30,000	$1.90	$57,000.00	Disclosure SEC source: 0001445866-17-001281 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,781,670 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. Read SEC document
August 25, 2017 Filed Aug 25, 2017 17:54 UTC	InfuSystem Holdings, Inc INFU · Entity 6163	PurchaseCommon Stock	11,060	$1.85	$20,461.00	Disclosure SEC source: 0001445866-17-001277 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,751,670 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.